BENDER ROBERT & ASSOCIATES – BioCryst Pharmaceuticals, Inc. Transaction History
BENDER ROBERT & ASSOCIATES portfolio value:
$864,000
portfolio value
BENDER ROBERT & ASSOCIATES quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 138K | $12.6 | 68.6K | |
| Q2 2022 | share | Increase | 0.00% | 68.6K shares | 726K | $10.58 | 68.6K |